<unk>  is an antimalarial that is FDA approved for the {{{indicationType}}} of acute attacks of malaria due to Plasmodium vivax, P. malariae, P. ovale and susceptible strains of P. falciparum, discoid and systemic lupus erythematosus, and rheumatoid arthritis. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include disorder of cornea, headache, dizziness, diarrhea, anorexia, nausea and abdominal cramps.
Hydroxychloroquine
Azathioprine
Teriflunomide
Leflunomide
Tofacitinib
Etanercept
Cyclizine
Prednisolone 